Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Birgit Burkhardt

Showing results (21-30 of 137) with videos related to

Pageof 14
Sort By:
Mycoses|July 24, 2019
Epidemiology and management burden of invasive fungal infections after autologous hematopoietic stem cell transplantation: 10-year experience at a European Pediatric Cancer CenterChristina Linke, Athanasios Tragiannidis, Martina Ahlmann, et al.
Mycoses|October 30, 2019
Epidemiology, utilisation of healthcare resources and outcome of invasive fungal diseases following paediatric allogeneic haematopoietic stem cell transplantationChristina Linke, Karoline Ehlert, Martina Ahlmann, et al.
Blood|February 27, 2010
Correlation of the autoantibody response to the ALK oncoantigen in pediatric anaplastic lymphoma kinase-positive anaplastic large cell lymphoma with tumor dissemination and relapse riskKamel Ait-Tahar, Christine Damm-Welk, Birgit Burkhardt, et al.
British Journal of Haematology|September 22, 2005
The impact of age and gender on biology, clinical features and treatment outcome of non-Hodgkin lymphoma in childhood and adolescenceBirgit Burkhardt, Martin Zimmermann, Ilske Oschlies, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 13, 2009
Poor outcome for children and adolescents with progressive disease or relapse of lymphoblastic lymphoma: a report from the berlin-frankfurt-muenster groupBirgit Burkhardt, Alfred Reiter, Eva Landmann, et al.
British Journal of Haematology|April 3, 2020
Experience with provisional WHO-entities large B-cell lymphoma with IRF4-rearrangement and Burkitt-like lymphoma with 11q aberration in paediatric patients of the NHL-BFM groupRex K H Au-Yeung, Laura Arias Padilla, Martin Zimmermann, et al.
Genes, Chromosomes & Cancer|March 12, 2022
Design of a targeted next-generation DNA sequencing panel for pediatric T-cell lymphoblastic lymphoma to unravel biology and optimize treatmentCharlotte Ruether, Christian Wuensch, Gerrit Randau, et al.
British Journal of Haematology|September 18, 2007
Clinical characteristics and treatment outcome of infants with non-Hodgkin lymphomaGeorg Mann, Andishe Attarbaschi, Birgit Burkhardt, et al.
Paediatric Drugs|December 26, 2022
Letermovir for Prophylaxis and Pre-emptive Therapy of Cytomegalovirus Infection in Paediatric Allogeneic Haematopoietic Cell Transplant PatientsKatharina F Körholz, Miriam A Füller, Marc Hennies, et al.
Journal of Viral Hepatitis|December 6, 2018
Durable control of hepatitis C through interferon-free antiviral combination therapy immediately prior to allogeneic haematopoietic stem cell transplantationKerstin Rauwolf, Heidi Herbrüggen, Stefan Zöllner, et al.
Pageof 14

Showing results (21-30 of 137) with videos related to

Sort By:
Pageof 14
Mycoses|July 24, 2019
Epidemiology and management burden of invasive fungal infections after autologous hematopoietic stem cell transplantation: 10-year experience at a European Pediatric Cancer CenterChristina Linke, Athanasios Tragiannidis, Martina Ahlmann, et al.
Mycoses|October 30, 2019
Epidemiology, utilisation of healthcare resources and outcome of invasive fungal diseases following paediatric allogeneic haematopoietic stem cell transplantationChristina Linke, Karoline Ehlert, Martina Ahlmann, et al.
Blood|February 27, 2010
Correlation of the autoantibody response to the ALK oncoantigen in pediatric anaplastic lymphoma kinase-positive anaplastic large cell lymphoma with tumor dissemination and relapse riskKamel Ait-Tahar, Christine Damm-Welk, Birgit Burkhardt, et al.
British Journal of Haematology|September 22, 2005
The impact of age and gender on biology, clinical features and treatment outcome of non-Hodgkin lymphoma in childhood and adolescenceBirgit Burkhardt, Martin Zimmermann, Ilske Oschlies, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 13, 2009
Poor outcome for children and adolescents with progressive disease or relapse of lymphoblastic lymphoma: a report from the berlin-frankfurt-muenster groupBirgit Burkhardt, Alfred Reiter, Eva Landmann, et al.
British Journal of Haematology|April 3, 2020
Experience with provisional WHO-entities large B-cell lymphoma with IRF4-rearrangement and Burkitt-like lymphoma with 11q aberration in paediatric patients of the NHL-BFM groupRex K H Au-Yeung, Laura Arias Padilla, Martin Zimmermann, et al.
Genes, Chromosomes & Cancer|March 12, 2022
Design of a targeted next-generation DNA sequencing panel for pediatric T-cell lymphoblastic lymphoma to unravel biology and optimize treatmentCharlotte Ruether, Christian Wuensch, Gerrit Randau, et al.
British Journal of Haematology|September 18, 2007
Clinical characteristics and treatment outcome of infants with non-Hodgkin lymphomaGeorg Mann, Andishe Attarbaschi, Birgit Burkhardt, et al.
Paediatric Drugs|December 26, 2022
Letermovir for Prophylaxis and Pre-emptive Therapy of Cytomegalovirus Infection in Paediatric Allogeneic Haematopoietic Cell Transplant PatientsKatharina F Körholz, Miriam A Füller, Marc Hennies, et al.
Journal of Viral Hepatitis|December 6, 2018
Durable control of hepatitis C through interferon-free antiviral combination therapy immediately prior to allogeneic haematopoietic stem cell transplantationKerstin Rauwolf, Heidi Herbrüggen, Stefan Zöllner, et al.
Pageof 14